Luca Mirra
Via Amadeo 42
Milan, 20133, Italy
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
USP18 Impacts Cisplatin Resistance in Ovarian Cancer Cells by Modulating DNA Repair.
Journal: International journal of biological sciences
Published: December 22, 2025
Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: April 16, 2025
Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery.
Journal: Stem cell research & therapy
Published: February 26, 2025
PSMC6 regulation of ovarian cancer cisplatin resistance unravels a new mode for proteasome targeting.
Journal: International journal of biological sciences
Published: October 03, 2024
Deubiquitinases in Ovarian Cancer: Role in Drug Resistance and Tumor Aggressiveness.
Journal: International journal of biological sciences
Published: July 01, 2024
Therapeutic Strategies to Improve the Treatment of Pleural Mesothelioma.
Journal: Current medicinal chemistry
Published: December 29, 2023
Synthesis of N-oxyamide analogues of protein kinase B (Akt) targeting anionic glycoglycerolipids and their antiproliferative activity on human ovarian carcinoma cells.
Journal: Organic & biomolecular chemistry
Published: August 01, 2023
Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells.
Journal: Frontiers in oncology
Published: March 09, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026